Detection of latent tuberculosis infection in individuals before heart transplantation and heart transplant recipients
Authors:
- A. R. SabirovaASA. R. Sabirova
- P. A. FedotovPFP. A. Fedotov
- R. A. SharipovRSR. A. Sharipov
- M. A. SimonenkoMSM. A. Simonenko
- B. B. MusaevaBMB. B. Musaeva
- E. Yu. VasilyevaEVE. Yu. Vasilyeva
- E. A. StabrovaESE. A. Stabrova
- I. V. KudryavtsevI. V. Kudryavtsev
- D. A. KudlayDKD. A. Kudlay
- A. A. StarshinovaA. A. Starshinova
- D. M. SpelnikovDSD. M. Spelnikov
Open Access
- 29 August 2026
- journal article
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 13 (3) , 206-218
Abstract
Background. The effective functioning of the immune system in solid organ recipients against M. tuberculosis may be compromised due to the intensive action of immunosuppressive drugs. Identifying latent tuberculosis infection (LTBI) in patients on the heart transplant waiting list, as well as in heart transplant recipients, may help improve the epidemic situation. Objective. To determent the level of latent tuberculosis infection in patients before and after heart transplantation. Materials and Methods. A comparative prospective cohort study was conducted using immunodiagnostic data from individuals prior to heart transplantation ( n =14) and recipients of a transplanted heart ( n =28). The control group consisted of healthy individuals ( n =69) with no history of contact with TB patients. All participants underwent immunodiagnosis for tuberculosis infection. Results. Positive results were recorded significantly more frequently in recipients of a transplanted heart compared to the control group (53.6 % versus 4.4 %, p =0.001). In the pre-transplant patient group, the level of positive immunodiagnostic results was also significantly higher (35.7 %) than in the control group ( p =0.001). Despite this, there were no statistically significant differences between the recipient group and the transplant candidate group ( p =0.275). Conclusion. The LTBI rate in recipients of a transplanted heart (53.6 %) was determined to be 1.5 times more frequent compared to patients awaiting transplantation (35.7 %). Notably, both comparison groups demonstrated a significantly high level of LTBI relative to healthy individuals (4.4 %), which necessitates further examination of this patient cohort and investigation into the causes of these findings.Keywords
This publication has 37 references indexed in Scilit:
- A novel application of the interferon-gamma release assay (IGRA) among end-stage heart failure patients awaiting heart transplantationJournal of Microbiology, Immunology and Infection, 2025
- Inflammation in heart failure: pathophysiology and therapeutic strategiesInflammation Research, 2024
- Immediate major dynamic changes in the T‐ and NK‐cell subset composition after cardiac transplantationEuropean Journal of Immunology, 2023
- Inflammation in Heart FailureJACC, 2020
- Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infectionJournal of Infection, 2020
- Prevalence of latent tuberculosis infection in transplant candidates: A systematic review and meta-analysisMicrobial Pathogenesis, 2018
- Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection FractionJACC, 2018
- Immune Mechanisms in Heart FailureEuropean Journal of Heart Failure, 2017
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection FractionJAMA, 2013
- T Cell Receptor Excision Circles (TRECs) in Relation to Acute Cardiac Allograft RejectionJournal of Clinical Immunology, 2004